ODDB.org: Open Drug Database

Irinotecan Sandoz 150 mg/7.5 ml, Infusionskonzentrat - Durchstechflasche(n)

Swissmedic Key	59438014	Registration Holder	Sandoz Pharmaceuticals AG
Name	Irinotecan Sandoz 150 mg/7.5 ml, Infusionskonzentrat	Date of registration	04.12.2009
		Introduction of Sequence	04.12.2009
ATC-Classification	Irinotecan (L01XX19)	Revision date
WHO	WHO-DDD	Valid until	03.12.2019
Index Therapeuticus (BSV)	07.16.10.	Show package size	Durchstechflasche(n)
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	158.91
Deductible	k.A.	Consumer price	198.85
Feedback	FB
GTIN	7680594380141	Medication Code	Synthetika human
Pharmacode		Disponibility

Composition

irinotecani hydrochloridum trihydricum 150 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 7.5 ml.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	150mg / 7.5ml

Source

Data was imported : 04.12.2014 Swissmedic Registration : 59438 Sequence : 03 Product name : Irinotecan Sandoz 150 mg/7.5 ml, Infusionskonzentrat Registration owner: : Sandoz Pharmaceuticals AG Product group : Index Therapeuticus (BSV) : 07.16.1. Medication Code : Synthetika human Date of registration : 04.12.2009 Valid until : 03.12.2019 Package number : 014 Show package size : 1 Commercial Form/Unit : Durchstechflasche(n) Swissmedic categorie. : A Active Agents : irinotecani hydrochloridum trihydricum Composition : irinotecani hydrochloridum trihydricum 150 mg, sorbitolum, acidum lacticum, aqua ad iniectabilia q.s. ad solutionem pro 7.5 ml.

2025	©ywesee GmbH